Early research (Phase 1)Study completedNCT00049296What this trial is testingThalidomide and Docetaxel in Treating Patients With Advanced CancerWho this might be right forCancer Case Comprehensive Cancer Center 26
Not applicableLooking for participantsNCT06651580What this trial is testingBiospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 StudyWho this might be right forChronic PancreatitisExocrine Pancreas CarcinomaRecurrent Acute Pancreatitis M.D. Anderson Cancer Center 1,600
Testing effectiveness (Phase 2)Study completedNCT01280058What this trial is testingCarboplatin and Paclitaxel With or Without Viral Therapy in Treating Patients With Recurrent or Metastatic Pancreatic CancerWho this might be right forPancreatic Acinar Cell CarcinomaPancreatic Ductal AdenocarcinomaRecurrent Pancreatic Carcinoma+1 more National Cancer Institute (NCI) 73
Not applicableStudy completedNCT00900016What this trial is testingStudying Fibroblast Activity in Patients With Localized Pancreatic Cancer Undergoing SurgeryWho this might be right forPancreatic Cancer Fox Chase Cancer Center 37
Testing effectiveness (Phase 2)Ended earlyNCT00084461What this trial is testingRomidepsin in Treating Patients With Locally Advanced or Metastatic Neuroendocrine TumorsWho this might be right forGastrinomaGlucagonomaInsulinoma+7 more National Cancer Institute (NCI) 25
Very early researchNot Yet RecruitingNCT06645301What this trial is testingBGT007 Treatment for Recurrent/refractory Gastrointestinal MalignanciesWho this might be right forColorectal CancerPancreatic Cancer BioSyngen Pte Ltd 15
Testing effectiveness (Phase 2)Study completedNCT00078975What this trial is testing3-AP and Gemcitabine in Treating Patients With Recurrent, Unresectable, or Metastatic Pancreatic CancerWho this might be right forPancreatic Cancer University Health Network, Toronto 26
Testing effectiveness (Phase 2)Study completedNCT02890355What this trial is testingFOLFIRI or Modified FOLFIRI and Veliparib as Second Line Therapy in Treating Patients With Metastatic Pancreatic CancerWho this might be right forMetastatic Pancreatic AdenocarcinomaRecurrent Pancreatic CarcinomaStage IV Pancreatic Cancer AJCC v6 and v7 National Cancer Institute (NCI) 123
Very early researchWithdrawnNCT05238831What this trial is testingSMMART Adaptive Clinical Treatment (ACT) TrialWho this might be right forAdvanced Breast CarcinomaAdvanced Malignant Solid NeoplasmAdvanced Ovarian Carcinoma+14 more OHSU Knight Cancer Institute
Large-scale testing (Phase 3)Study completedNCT00044031What this trial is testingSafety and Efficacy of G17DT Immunogen Combined With Gemcitabine vs. Gemcitabine in the Treatment of Advanced Pancreatic CarcinomaWho this might be right forPancreatic Cancer Cancer Advances Inc. 394
Early research (Phase 1)Study completedNCT00073944What this trial is testingBCX-1777 in Treating Patients With Refractory CancerWho this might be right forCancer BioCryst Pharmaceuticals
Early research (Phase 1)Study completedNCT01410968What this trial is testingA Feasibility and Safety Study of Vaccination With Poly-ICLC and Peptide-pulsed Dendritic Cells in Patients With Metastatic, Locally Advanced, Unresectable, or Recurrent Pancreatic AdenocarcinomaWho this might be right forMetastatic Pancreatic Cancer Carolyn Britten 12
Very early researchEnded earlyNCT00867126What this trial is testingPioglitazone as Second-Line in Patients With Metastatic Pancreatic Cancer After Treatment With GemcitabineWho this might be right forPancreatic Cancer University of Texas Southwestern Medical Center 6
Early research (Phase 1)Study completedNCT00006368What this trial is testingYttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent CancerWho this might be right forBrain and Central Nervous System TumorsBreast CancerGastrointestinal Carcinoid Tumor+5 more Novartis Pharmaceuticals 60
Testing effectiveness (Phase 2)Study completedNCT00003951What this trial is testingDX-8951f in Treating Patients With Metastatic Cancer of the PancreasWho this might be right forPancreatic Cancer Daiichi Sankyo 37
Not applicableStudy completedNCT01219829What this trial is testingPancreatic Intraepithelial Neoplasia (PanIN) and the Association With Recurrence of Pancreatic AdenocarcinomaWho this might be right forPancreatic Cancer Columbia University 5
Early research (Phase 1)Study completedNCT01839981What this trial is testingCPI-613 in Treating Patients With Locally Advanced or Metastatic Pancreatic CancerWho this might be right forAcinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasRecurrent Pancreatic Cancer+2 more Wake Forest University Health Sciences 10
Testing effectiveness (Phase 2)Looking for participantsNCT03175224What this trial is testingAPL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid TumorsWho this might be right forSolid TumorsAdvanced CancerRenal Cancer+15 more Apollomics Inc. 497
Not applicableUnknownNCT05830019What this trial is testingCarbon Ion Radiotherapy for Recurrent Pancreatic Cancer Post SurgeryWho this might be right forPancreatic Carcinoma Shanghai Proton and Heavy Ion Center 49
Not applicableStudy completedNCT00477919What this trial is testingE-MOSAIC Electronic Tool to Monitor SymptomsWho this might be right forCancer Swiss Cancer Institute 264